دورية أكاديمية
35MO Number of IL-2 doses and clinical outcomes of tumor-infiltrating lymphocyte (TIL) cell therapy: Post hoc analysis of the C-144-01 trial of lifileucel in patients with advanced melanoma
| العنوان: | 35MO Number of IL-2 doses and clinical outcomes of tumor-infiltrating lymphocyte (TIL) cell therapy: Post hoc analysis of the C-144-01 trial of lifileucel in patients with advanced melanoma |
|---|---|
| المؤلفون: | Hassel, J.C., Sarnaik, A., Chesney, J., Medina, T., Hamid, O., Thomas, S., Wermke, M., Domingo-Musibay, E., Kirkwood, J.M., Larkin, J., Weber, J.S., Arance Fernandez, A.M., Rodriguez, J.F., Thomas, I., Corrie, P.G., Gontcharova, V., Wu, X., Shi, W., Kluger, H. |
| المصدر: | Immuno-Oncology and Technology ; volume 16, page 100140 ; ISSN 2590-0188 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Immunology and Allergy |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.iotech.2022.100140 |
| الإتاحة: | https://doi.org/10.1016/j.iotech.2022.100140Test https://api.elsevier.com/content/article/PII:S2590018822000715?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2590018822000715?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.54FD6DA7 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.iotech.2022.100140 |
|---|